| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Faculty of Medicine-Endocrinology, Memorial University of Newfoundland (C.S.K., L.L.C., N.J.F.), St. Johns, Newfoundland, Canada A1B 3V6; Department of Biochemistry and Pediatrics, Memorial University of Newfoundland (J.F.K.), St. Johns, Newfoundland, Canada A1B 3X9; and Institute of Molecular Medicine and Genetics, Department of Pediatrics, Medical College of Georgia (N.R.M.), Augusta, Georgia 30912-2640
Address all correspondence and requests for reprints to: Dr. Christopher S. Kovacs, Faculty of Medicine-Endocrinology, Memorial University of Newfoundland, 300 Prince Philip Drive, St. Johns, Newfoundland, Canada A1B 3V6. E-mail: ckovacs{at}mun.ca
PTH and PTHrP both act in the regulation of fetal mineral metabolism. PTHrP regulates placental calcium transfer, fetal blood calcium, and differentiation of the cartilaginous growth plate into endochondral bone. PTH has been shown to influence fetal blood calcium, but its role in skeletal formation remains undefined. We compared skeletal morphology, mineralization characteristics, and gene expression in growth plates of fetal mice that lack parathyroids and PTH (Hoxa3 null) with the effects of loss of PTHrP (Pthrp null), loss of PTH/PTHrP receptor (Pthr1 null), and loss of both PTH and PTHrP (Hoxa3 null x Pthrp null). Loss of PTH alone does not affect morphology or gene expression in the skeletal growth plates, but skeletal mineralization and blood calcium are significantly reduced. In double-mutant fetuses (Hoxa3 null/Pthrp null), combined loss of PTH and PTHrP caused fetal growth restriction, limb shortening, greater reduction of fetal blood calcium, and reduced mineralization. These findings suggest that 1) PTH may play a more dominant role than PTHrP in regulating fetal blood calcium; 2) blood calcium and PTH levels are rate-limiting determinants of skeletal mineral accretion; and 3) lack of both PTH and PTHrP will cause fetal growth restriction.
This article has been cited by other articles:
![]() |
C. S. Kovacs, M. L. Woodland, N. J. Fudge, and J. K. Friel The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E133 - E144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wlodek, K. T. Westcott, R. O'Dowd, A. Serruto, L. Wassef, K. M. Moritz, and J. M. Moseley Uteroplacental restriction in the rat impairs fetal growth in association with alterations in placental growth factors including PTHrP Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1620 - R1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. McDonald, N. J. Fudge, J. P. Woodrow, J. K. Friel, A. O. Hoff, R. F. Gagel, and C. S. Kovacs Ablation of calcitonin/calcitonin gene-related peptide-{alpha} impairs fetal magnesium but not calcium homeostasis Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E218 - E226. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kovacs, L. L. Chafe, M. L. Woodland, K. R. McDonald, N. J. Fudge, and P. J. Wookey Calcitropic gene expression suggests a role for the intraplacental yolk sac in maternal-fetal calcium exchange Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E721 - E732. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |